The prospectus states an objective of current income and long-term capital appreciation. The Fund invests primarily in alternative and esoteric 'longevity-based' assets, mainly through structured products tied to life settlements, structured settlements and pharmaceutical royalties, plus private debt, senior-living real estate, private funds and public securities. It invests at least 80% of net assets in alternative assets, concentrates 25% or more in the insurance industry, may hold below-investment-grade debt, and may use leverage.